These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 34297039)
41. PACT Facilitates RNA-Induced Activation of MDA5 by Promoting MDA5 Oligomerization. Lui PY; Wong LR; Ho TH; Au SWN; Chan CP; Kok KH; Jin DY J Immunol; 2017 Sep; 199(5):1846-1855. PubMed ID: 28760879 [TBL] [Abstract][Full Text] [Related]
42. Adenosine deaminases that act on RNA, then and now. Bass BL RNA; 2024 Apr; 30(5):521-529. PubMed ID: 38531651 [TBL] [Abstract][Full Text] [Related]
43. Interplay between A-to-I Editing and Splicing of RNA: A Potential Point of Application for Cancer Therapy. Goncharov AO; Shender VO; Kuznetsova KG; Kliuchnikova AA; Moshkovskii SA Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563631 [TBL] [Abstract][Full Text] [Related]
44. Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss. Liu H; Golji J; Brodeur LK; Chung FS; Chen JT; deBeaumont RS; Bullock CP; Jones MD; Kerr G; Li L; Rakiec DP; Schlabach MR; Sovath S; Growney JD; Pagliarini RA; Ruddy DA; MacIsaac KD; Korn JM; McDonald ER Nat Med; 2019 Jan; 25(1):95-102. PubMed ID: 30559422 [TBL] [Abstract][Full Text] [Related]
45. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. Chen CX; Cho DS; Wang Q; Lai F; Carter KC; Nishikura K RNA; 2000 May; 6(5):755-67. PubMed ID: 10836796 [TBL] [Abstract][Full Text] [Related]
46. MDA5 disease variant M854K prevents ATP-dependent structural discrimination of viral and cellular RNA. Yu Q; Herrero Del Valle A; Singh R; Modis Y Nat Commun; 2021 Nov; 12(1):6668. PubMed ID: 34795277 [TBL] [Abstract][Full Text] [Related]
47. Adenosine-to-Inosine RNA Editing of Alu Double-Stranded (ds)RNAs Is Markedly Decreased in Multiple Sclerosis and Unedited Alu dsRNAs Are Potent Activators of Proinflammatory Transcriptional Responses. Tossberg JT; Heinrich RM; Farley VM; Crooke PS; Aune TM J Immunol; 2020 Nov; 205(10):2606-2617. PubMed ID: 33046502 [TBL] [Abstract][Full Text] [Related]
48. Mechanisms and implications of ADAR-mediated RNA editing in cancer. Wang C; Zou J; Ma X; Wang E; Peng G Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449 [TBL] [Abstract][Full Text] [Related]
50. Junctophilin-2 is a double-stranded RNA-binding protein that regulates cardiomyocyte-autonomous innate immune response. Shi Y; Mirabdali S; Vetter SW; Guo A Biochem Biophys Res Commun; 2024 Nov; 733():150725. PubMed ID: 39317111 [TBL] [Abstract][Full Text] [Related]
51. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Ishizuka JJ; Manguso RT; Cheruiyot CK; Bi K; Panda A; Iracheta-Vellve A; Miller BC; Du PP; Yates KB; Dubrot J; Buchumenski I; Comstock DE; Brown FD; Ayer A; Kohnle IC; Pope HW; Zimmer MD; Sen DR; Lane-Reticker SK; Robitschek EJ; Griffin GK; Collins NB; Long AH; Doench JG; Kozono D; Levanon EY; Haining WN Nature; 2019 Jan; 565(7737):43-48. PubMed ID: 30559380 [TBL] [Abstract][Full Text] [Related]
52. DNAJB1/HSP40 Suppresses Melanoma Differentiation-Associated Gene 5-Mitochondrial Antiviral Signaling Protein Function in Conjunction with HSP70. Takashima K; Oshiumi H; Matsumoto M; Seya T J Innate Immun; 2018; 10(1):44-55. PubMed ID: 29069650 [TBL] [Abstract][Full Text] [Related]
53. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Valente L; Nishikura K Prog Nucleic Acid Res Mol Biol; 2005; 79():299-338. PubMed ID: 16096031 [No Abstract] [Full Text] [Related]
54. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer. Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428 [TBL] [Abstract][Full Text] [Related]
55. Positive correlation between ADAR expression and its targets suggests a complex regulation mediated by RNA editing in the human brain. Liscovitch N; Bazak L; Levanon EY; Chechik G RNA Biol; 2014; 11(11):1447-56. PubMed ID: 25692240 [TBL] [Abstract][Full Text] [Related]
56. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2. Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133 [TBL] [Abstract][Full Text] [Related]
57. The dsRBP and inactive editor ADR-1 utilizes dsRNA binding to regulate A-to-I RNA editing across the C. elegans transcriptome. Washburn MC; Kakaradov B; Sundararaman B; Wheeler E; Hoon S; Yeo GW; Hundley HA Cell Rep; 2014 Feb; 6(4):599-607. PubMed ID: 24508457 [TBL] [Abstract][Full Text] [Related]
58. RNA editing by ADAR1 marks dsRNA as "self". Yu Z; Chen T; Cao X Cell Res; 2015 Dec; 25(12):1283-4. PubMed ID: 26596786 [TBL] [Abstract][Full Text] [Related]
59. The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1. Herbert A; Rich A Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12132-7. PubMed ID: 11593027 [TBL] [Abstract][Full Text] [Related]
60. Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. Freund EC; Sapiro AL; Li Q; Linder S; Moresco JJ; Yates JR; Li JB Cell Rep; 2020 May; 31(7):107656. PubMed ID: 32433965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]